Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors

被引:2
|
作者
Shiraishi, Takuya [1 ]
Kadono, Shojiro [1 ]
Haramura, Masayuki [1 ]
Kodama, Hirofumi [1 ]
Ono, Yoshiyuki [1 ]
Iikura, Hitoshi [1 ]
Esaki, Tohru [1 ]
Koga, Takaki [1 ]
Hattori, Kunihiro [1 ]
Watanabe, Yoshiaki [1 ]
Sakamoto, Akihisa [1 ]
Yoshihashi, Kazutaka [1 ]
Kitazawa, Takehisa [1 ]
Esaki, Keiko [1 ]
Ohta, Masateru [1 ]
Sato, Haruhiko [1 ]
Kozono, Toshiro [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka 4128513, Japan
关键词
factor VIIa; X-ray; 2Xactivated partial thromboplastin time/2Xprothrombin time; thromboembolic disorder; peptidomimetic inhibitor; FACTOR-VIIA/TISSUE-FACTOR; COAGULATION-FACTOR VIIA; TISSUE FACTOR MUTANT; CRYSTAL-STRUCTURE; P3; MOIETIES; FACTOR XA; COMPLEX; THROMBOSIS; OPTIMIZATION; EFFICACY;
D O I
10.1248/cpb.58.38
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Selective factor Vila-tissue factor complex (FVIIa/TF) inhibition is regarded as a promising target for developing new anticoagulant drugs. In previous reports, we described a S3 subsite found in the X-ray crystal structure of compound 2 that bound to FVIIa/soluble tissue factor (sTF). Based on the X-ray crystal structure information and with the aim of improving the inhibition activity for FVIIa/TF and selectivity against other serine proteases, we synthesized derivatives by introducing substituents at position 5 of the indole ring of compound 2. Among them, compound 16 showed high selectivity against other serine proteases. Contrary to our expectations, compound 16 did not occupy the S3-subsite; X-ray structure analysis revealed that compound 16 improved selectivity by forming hydrogen bonds with Gln217, Thr99 and Asn100.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [31] In silico design, synthesis, and assays of specific substrates and peptidomimetic inhibitors for proteinase 3
    Narawane, Shailesh
    Grauffel, Cedric
    Schillinger, Anne-Sophie
    Haug, Bengt Erik
    Reuter, Nathalie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [32] Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors
    Parlow, JJ
    Stevens, AM
    Stegeman, RA
    Stallings, WC
    Kurumbail, RG
    South, MS
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) : 4297 - 4312
  • [33] Synthesis and activity of novel sulfur-containing peptidomimetic inhibitors of tumor necrosis factor
    Key Laboratory of Bioorganic Chemistry and Molecular Engineering, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China
    Kao Teng Hsueh Hsiao Hua Heush Hsueh Pao, 2006, 4 (669-671):
  • [34] Rational design and development of peptidomimetic Cbl inhibitors
    Kumar, Eric A.
    Chen, Qianyi
    Natarajan, Amarnath
    BIOPOLYMERS, 2011, 96 (04) : 460 - 460
  • [35] Design of peptidomimetic farnesyltransferase inhibitors as anticancer agents
    Ro, S
    Lee, J
    Baek, SG
    Cho, HY
    Kim, JH
    Shin, DK
    Jung, WH
    Park, C
    Lee, H
    Shin, YS
    Ahn, IA
    Yoo, JK
    Kim, M
    Park, K
    Moon, K
    Chung, HH
    Koh, JS
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 461 - 462
  • [36] Discovery of potent neutral factor VIIa inhibitors
    Wurtz, Nicholas R.
    Parkhurst, Brandon L.
    Jiang, Wen
    DeLucca, Indawati
    Zhang, Xiaojun
    Cheney, Daniel
    Rendina, Alan
    Metzler, William
    Wei, Anzhi
    Luettgen, Joseph
    Wong, Pancras
    Seiffert, Dietmar
    Wexler, Ruth R.
    Priestley, E. Scott
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [37] Atropisomer Control in Macrocyclic Factor VIIa Inhibitors
    Glunz, Peter W.
    Mueller, Luciano
    Cheney, Daniel L.
    Ladziata, Vladimir
    Zou, Yan
    Wurtz, Nicholas R.
    Wei, Anzhi
    Wong, Pancras C.
    Wexler, Ruth R.
    Priestley, E. Scott
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 4007 - 4018
  • [38] Peptide exosite inhibitors of factor VIIa as anticoagulants
    Dennis, MS
    Eigenbrot, C
    Skelton, NJ
    Ultsch, MH
    Santell, L
    Dwyer, MA
    O'Connell, MP
    Lazarus, RA
    NATURE, 2000, 404 (6777) : 465 - 470
  • [39] Factor VIIa inhibitors: Improved pharmacokinetic parameters
    Kolesnikov, A
    Rai, R
    Young, WB
    Mordent, J
    Liu, L
    Torkelson, S
    Shrader, WD
    Leahy, EM
    Hu, HY
    Gjerstad, E
    Janc, J
    Katz, BA
    Sprengeler, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2243 - 2246
  • [40] Synthesis and activity of novel sulfur-containing peptidomimetic inhibitors of tumor necrosis factor
    Wang, D
    Zhang, QH
    Xu, JX
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2006, 27 (04): : 669 - 671